Clario Acquires WCG's eCOA Business

May 6, 2025

Clario has acquired the electronic clinical outcome assessment (eCOA) business of WCG to expand its endpoint data solutions and deepen neuroscience-focused clinical outcomes expertise. The deal—announced in March and completed in May 2025—transfers WCG’s eCOA team and capabilities to Clario and is expected to enhance Clario’s support for complex neuroscience clinical trials.

Buyers
Clario
Targets
WCG's eCOA business
Sellers
WCG
Location
North Carolina, United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.